Patient Afib Case Study

1191 Words 5 Pages
Patient Afib is a 58 year old, Caucasian, married male. The patient has been healthy most of his life with no significant health issues until the beginning of this year. One night, in April of 2016, patient Afib began to experience chest pain, shortness of breath, nausea, and vomiting prompting him to visit the emergency room. Subsequent tests revealed that patient Afib had symptomatic atrial fibrillation. Physicians in the ER stated that patient Afib probably had had atrial fibrillation for a while, but it had been exacerbated for an unknown reason. The emergency room physician advised patient Afib to visit a cardiologist to figure out why the arrhythmia had begun and how to fix it. After consultation with a cardiologist and a sleep study, …show more content…
Physicians prescribed this drug in order to determine if patient Afib’s shortness of breath was due to his atrial fibrillation and not due to underlying asthma that had not been noted before. Proair HFA is one of the many trade names for albuterol sulfate. This manufacturer, along with others, now uses HFA (hyrdofluoroalkane) instead of CFC’s as a propellant in their meter dose inhalers since there were concerns about CFC’s contributing to ozone depletion (Swisher, n.d.). Albuterol works by acting as an agonist of β2 adrenergic receptors responsible for bronchodilation, uterine relaxation, and vasodilation of the arterioles in the lungs, heart, and skeletal muscle (Usher, n.d.c). Albuterol, used primarily as a rescue inhaler, utilizes the bronchodilation component of β2 adrenergic receptor stimulation in order to treat bronchospasms caused by asthma. Once inhaled, albuterol takes 5 to 15 minutes to take effect and its effects can last anywhere from three to six hours (Usher, n.d.b). Patient Afib was instructed to take Proair HFA as needed for shortness of breath. After taking it for a couple months it was determined that patient Afib’s shortness of breath was likely caused by his atrial fibrillation and not asthma. It is likely physicians will soon discontinue patient Afib’s prescription for this …show more content…
It is given to prevent the recurrence of atrial fibrillation after a cardioversion or if the patient has spontaneously returned to normal sinus rhythm. Multaq has a half-life of 24 hours and is usually given in 400 mg tablets that are taken twice daily (Camm & Savelieva, 2010). Patient Afib was prescribed Multaq after his ablation in order to keep him in him in a normal sinus rhythm. He takes two 400 mg tablets twice a day, one at breakfast and one at dinner. Common side effects of Multaq include, but are not limited to nausea, diarrhea, weakness, skin rash, and itchiness (“Multaq: Uses, Dosage, Side Effects,” n.d.). Patient Afib noted that he often has nausea and at times he feels weak and has trouble doing tasks he used to be able to do

Related Documents